Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 26 Sarcoma 16 Neoplasm Metastasis 12 Carcinoma, Non-Small-Cell Lung 9 Ovarian Neoplasms 8 Breast Neoplasms 8 Recurrence 6 Neoplasms 5 Melanoma 4 Liposarcoma 4 Leiomyosarcoma 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Neuroendocrine Tumors 3 Lung Neoplasms 3 Kidney Neoplasms 3 Hemangiosarcoma 3 Gastrointestinal Stromal Tumors 3 Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Sarcoma, Synovial 2 Sarcoma, Alveolar Soft Part 2 Rhabdomyosarcoma 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Gliosarcoma 2

Interventions

Oxaliplatin 5 Capecitabine 5 Paclitaxel 4 apatinib 3 Fluorouracil 3 Docetaxel 3 Cisplatin 3 S 1 (combination) 2 Leucovorin 2 titanium silicide 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 linrodostat 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 camrelizumab 1 Sunitinib 1 SHR-1701 1 Nivolumab 1 Ipilimumab 1 HMPL-013 1 Epirubicin 1 Doxorubicin 1 CF regimen 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Gastric Cancer × pazopanib × Clear all

NCT01503372 2019-02-12

PaFLO

Charite University, Berlin, Germany

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡